Canada markets closed

Cumberland Pharmaceuticals Inc. (CPIX)

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
1.7600+0.1250 (+7.65%)
At close: 04:00PM EDT
1.7700 +0.01 (+0.57%)
After hours: 04:00PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 24.95M
Enterprise Value 25.06M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)0.64
Price/Book (mrq)0.84
Enterprise Value/Revenue 0.63
Enterprise Value/EBITDA 10.08

Trading Information

Stock Price History

Beta (5Y Monthly) 0.17
52-Week Change 33.53%
S&P500 52-Week Change 322.36%
52 Week High 32.3600
52 Week Low 31.4300
50-Day Moving Average 31.8472
200-Day Moving Average 31.8281

Share Statistics

Avg Vol (3 month) 39.43k
Avg Vol (10 day) 34.94k
Shares Outstanding 514.18M
Implied Shares Outstanding 614.18M
Float 88.02M
% Held by Insiders 144.06%
% Held by Institutions 115.57%
Shares Short (Apr 15, 2024) 417.31k
Short Ratio (Apr 15, 2024) 41.61
Short % of Float (Apr 15, 2024) 40.22%
Short % of Shares Outstanding (Apr 15, 2024) 40.12%
Shares Short (prior month Mar 15, 2024) 420.44k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin -15.88%
Operating Margin (ttm)-30.31%

Management Effectiveness

Return on Assets (ttm)-4.44%
Return on Equity (ttm)-19.41%

Income Statement

Revenue (ttm)39.55M
Revenue Per Share (ttm)2.77
Quarterly Revenue Growth (yoy)2.50%
Gross Profit (ttm)N/A
EBITDA -1.27M
Net Income Avi to Common (ttm)-6.28M
Diluted EPS (ttm)-0.4400
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)18.32M
Total Cash Per Share (mrq)1.29
Total Debt (mrq)18.43M
Total Debt/Equity (mrq)62.98%
Current Ratio (mrq)1.28
Book Value Per Share (mrq)2.10

Cash Flow Statement

Operating Cash Flow (ttm)6.09M
Levered Free Cash Flow (ttm)9.33M